Hepatocyte growth factor-like protein is a positive regulator of early mammary gland ductal morphogenesis

被引:14
作者
Gurusamy, Devikala [1 ]
Ruiz-Torres, Sasha J. [1 ]
Johnson, Abby L. [2 ]
Smith, Dana A. [1 ]
Waltz, Susan E. [1 ,3 ]
机构
[1] Univ Cincinnati, Coll Med, Dept Canc Biol, Cincinnati, OH 45267 USA
[2] Univ Cincinnati, Coll Med, Dept Environm Hlth, Cincinnati, OH 45267 USA
[3] Cincinnati Vet Hosp, Med Ctr, Res Serv, Cincinnati, OH 45267 USA
关键词
HGFL; Ron receptor; Cell turnover; Macrophages; STAT3; Mammary gland development; MACROPHAGE-STIMULATING PROTEIN; RECEPTOR TYROSINE KINASE; TERMINAL END BUD; BREAST-CANCER; BRANCHING MORPHOGENESIS; TUMOR-GROWTH; CROSS-TALK; RON GENE; FACTOR I; ACTIVATION;
D O I
10.1016/j.mod.2014.07.002
中图分类号
Q [生物科学];
学科分类号
07 ; 0710 ; 09 ;
摘要
The Ron receptor tyrosine kinase regulates multiple cellular processes and is important during mammary gland development and tumor progression. Hepatocyte growth factor-like protein [HGFL] is the only known ligand for the Ron receptor and recent studies have identified major roles for HGFL during breast cancer metastasis. Understanding the functional importance HGFL during mammary gland development will provide significant insights onto its contribution during tumor development and metastasis. In this study, we assessed the role of HGFL during postnatal mammary gland development using mice that were either proficient [HGFL +/+] or deficient [HGFL-/-] for HGFL. Postnatal ductal morphology and stromal cell associations were analyzed at multiple time points through puberty until adulthood. HGFL deficiency resulted in several mammary gland developmental defects including smaller terminal end buds [TEBs], significantly fewer TEBs, and delayed ductal outgrowth during early puberty. Additionally, HGFL deficient animals exhibited significantly altered TEB epithelial cell turnover with decreased proliferation and increased apoptosis coupled with decreased TEB diameter. Macrophage recruitment to the TEBs was also significantly decreased in the HGFL-/- mice compared to controls. Moreover, the levels of STAT3 mRNA as well as the phosphorylation status of this protein were lower in the HGFL-/- mammary glands compared to controls. Taken together, our data provide the first evidence for HGFL as a positive regulator of mammary gland ductal morphogenesis by controlling overall epithelial cell turnover, macrophage recruitment, and STAT3 activation in the developing mammary gland. With a function in early mammary gland development, HGFL represents a potential target for the development of novel breast cancer therapies. (C) 2014 Elsevier Ireland Ltd. All rights reserved.
引用
收藏
页码:11 / 22
页数:12
相关论文
共 48 条
[1]   Roles of STAT3 defined by tissue-specific gene targeting [J].
Akira, S .
ONCOGENE, 2000, 19 (21) :2607-2611
[2]  
Ball SM, 1998, ANAT REC, V250, P459, DOI 10.1002/(SICI)1097-0185(199804)250:4<459::AID-AR9>3.0.CO
[3]  
2-S
[4]   Stat3 is tyrosine-phosphorylated through the interleukin-6/glycoprotein 130/Janus kinase pathway in breast cancer [J].
Berishaj, Marjan ;
Gao, Sizhi Paul ;
Ahmed, Simi ;
Leslie, Kenneth ;
Al-Ahmadie, Hikmat ;
Gerald, William L. ;
Bornmann, William ;
Bromberg, Jacqueline F. .
BREAST CANCER RESEARCH, 2007, 9 (03)
[5]   Biological effects of targeted inactivation of hepatocyte growth factor-like protein in mice [J].
Bezerra, JA ;
Carrick, TL ;
Degen, JL ;
Witte, D ;
Degen, SJF .
JOURNAL OF CLINICAL INVESTIGATION, 1998, 101 (05) :1175-1183
[6]  
BEZERRA JA, 1993, PROTEIN SCI, V2, P666
[7]   Coordinate expression and functional profiling identify an extracellular proteolytic signaling pathway [J].
Bhatt, Ami S. ;
Welm, Alana ;
Farady, Christopher J. ;
Vasquez, Maximiliano ;
Wilson, Keith ;
Craik, Charles S. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2007, 104 (14) :5771-5776
[8]   EGF RECEPTOR EXPRESSION, REGULATION, AND FUNCTION IN BREAST-CANCER [J].
CHRYSOGELOS, SA ;
DICKSON, RB .
BREAST CANCER RESEARCH AND TREATMENT, 1994, 29 (01) :29-40
[9]  
Danilkovitch-Miagkova A, 2001, HISTOL HISTOPATHOL, V16, P623, DOI 10.14670/HH-16.623
[10]   Oncogenic Signaling Pathways Activated by RON Receptor Tyrosine Kinase [J].
Danilkovitch-Miagkova, Alla .
CURRENT CANCER DRUG TARGETS, 2003, 3 (01) :31-40